Ordinary Adjustment | Solactive China Biohealthcare Index | Effective Date 2nd February 2026
Solactive China Biohealthcare Index:
In the ordinary adjustment, the following composition will be implemented effective open 2nd February 2026:
| 3SBIO INC |
| AB&B BIO-TECH-B ORD H |
| AKESO INC |
| ASCENTAGE PHARMA GROUP INTERNATIONAL |
| ASCLETIS PHARMA INC |
| BEONE MEDICINES LTD |
| CHINA MEDICAL SYSTEM HOLDINGS LTD |
| CSPC PHARMACEUTICAL GROUP LTD |
| DUALITYBIO-B ORD |
| EVEREST MEDICINES LTD |
| GENSCRIPT BIOTECH CORP |
| GRAND PHARMACEUTICAL GROUP LTD |
| HANSOH PHARMACEUTICAL GROUP CO |
| HBM HOLDINGS LTD |
| HENGRUI PHARMA ORD H |
| HUTCHMED CHINA LTD |
| INNOCARE PHARMA LTD |
| INNOVENT BIOLOGICS INC |
| KEYMED BIOSCIENCES INC |
| REMEGEN CO LTD-H |
| SIHUAN PHARMACEUTICAL HLDGS GRP ORD |
| SIMCERE PHARMACEUTICAL GROUP |
| SINO BIOPHARMACEUTICAL LTD ORD |
| SKB BIO-B ORD H |
| TRANSTHERA-B ORD H |
| UNITED LABORATORIES INTERNATIONAL HOLDINGS LTD. |
| WUXI APPTEC CO LTD |
| WUXI BIOLOGICS CAYMAN INC |
| XTALPI HOLDINGS LTD |
| ZAI LAB LTD |